Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

Technologies Corporation (NASDAQ:NMTC), a medical technology firm specializing in neurological surgical solutions with a market capitalization of $32 million, has recently announced it has met ...

Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Moderna (NASDAQ: NASDAQ:MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ:BNTX) shares fell 1.5% following the Senate Finance Committee's vote to advance Robert F. Kennedy Jr.'s nomination for ...

Cytokinetics , Inc. (NASDAQ:CYTK), with a market capitalization of $5.65 billion, is approaching a pivotal moment in its journey to become a leading player in the cardiovascular therapeutics market.

Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease.

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) rose 5% Tuesday morning on news the FDA has approved its wearable treatment device Onapgo, formerly known as SPN-830, for the treatment of patients ...

Some calm is returning to Wall Street, and U.S. stock indexes are making only modest moves after much of Europe and Asia rose ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...